Clinical Research Directory
Browse clinical research sites, groups, and studies.
Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT
Sponsor: University of California, San Diego
Summary
The objective of this pilot study is to compare the effectiveness of mailed outreach of two stool based tests, Cologuard and the fecal immunochemical test (FIT) in screening eligible adults ages 45-49 receiving care at the University of California San Diego Health system.
Official title: Comparative Effectiveness Pilot Trial of Mailed Cologuard Outreach to Mailed FIT Outreach
Key Details
Gender
All
Age Range
45 Years - 49 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-05-15
Completion Date
2025-12
Last Updated
2025-11-04
Healthy Volunteers
No
Conditions
Interventions
Cologuard
Multi-target stool DNA test for colorectal cancer screening implemented by Exact Sciences. Cologuard has 94% sensitivity and 87% specificity to detect colorectal cancer.
Fecal Immunochemical Test
Stool blood test for colorectal cancer screening. FIT has 75% sensitivity and 90% specificity to detect colorectal cancer.
Locations (1)
University of California San Diego
La Jolla, California, United States